Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells

Mol Cell Endocrinol. 2021 Feb 15:522:111126. doi: 10.1016/j.mce.2020.111126. Epub 2020 Dec 13.

Abstract

Diabetes is a genetically heterogeneous disease, for which we are aiming to identify causative genes. Here, we report a missense mutation (c.T1424C:p.L475P) in ZYG11A identified by exome sequencing as segregating with hyperglycemia in a Thai family with autosomal dominant diabetes. ZYG11A functions as a target recruitment subunit of an E3 ubiquitin ligase complex that plays an important role in the regulation of cell cycle. We demonstrate an increase in cells arrested at G2/mitotic phase among beta-cells deficient for ZYG11A or overexpressing L475P-ZYG11A, which is associated with a decreased growth rate. This is the first evidence linking a ZYG11A mutation to hyperglycemia, and suggesting ZYG11A as a cell cycle regulator required for beta-cell growth. Since most family members were either overweight or obese, but only mutation carriers developed hyperglycemia, our data also suggests the ZYG11A mutation as a genetic factor predisposing obese individuals to beta-cell failure in maintenance of glucose homeostasis.

Keywords: Cell cycle arrest; Familial diabetes of adulthood; Mutation; ZYG11A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amino Acid Sequence
  • Cell Cycle Checkpoints / genetics*
  • Cell Cycle Proteins / chemistry
  • Cell Cycle Proteins / genetics*
  • Cell Proliferation / genetics
  • Chromosome Segregation / genetics
  • Diabetes Mellitus / genetics*
  • Exome / genetics
  • Female
  • Genes, Dominant*
  • Humans
  • Insulin-Secreting Cells / pathology*
  • Male
  • Middle Aged
  • Models, Biological
  • Models, Molecular
  • Mutation / genetics*
  • Pedigree

Substances

  • Cell Cycle Proteins
  • ZYG11A protein, human